Mace lands £150m life sciences contract
Mace has won a major life sciences job in London’s King’s Cross. Precis Group has awarded the company the contract to build a new headquarters for Merck
Source: constructionnews.co.uk
📰 Merck Sharp News
Page 49 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
Alzheimer's Disease Therapeutics Market Report Research 2022: Increasing Gap of Unmet Need of Effective Therapeutics
/PRNewswire/ -- The "Alzheimers Disease Therapeutics (2022 Edition) - Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of...
Source: prnewswire.com
Hundreds of genetic discoveries from FinnGen study
New results from the FinnGen research consortium include previously unknown genetic risk factors for many debilitating diseases.
Source: labiotech.eu
DelveInsight Business Research, LLP: Significant Positive Shift in the Malignant Pleural Mesothelioma Market with 5.7% CAGR During the Study Period (2019-2032) Expected by Analysts at DelveInsight
The dynamics of the malignant pleural mesothelioma market are anticipated to change in the coming years owing to the increasing awareness and expected increase in investment in the R&D activities.
United States United Kingdom Shruti Thakur Astrazeneca Imfinzi Kostenloser Wertpapierhandel Pharmamar Lurbinectedin
Source: finanznachrichten.de
Eisai Aims to Advance Gastrointestinal Cancer Treatment with Research Across Multiple Tumor Types at ASCO GI 2023
Highlights Include an Update from the Dose Escalation Part of a Phase 1 Study Evaluating the Novel Anticancer Agent, E7386, in Advanced Solid Tumors Including Colorectal CancerResearch from the LEAP (LEnvatinib
Source: finanznachrichten.de
Significant Positive Shift in the Malignant Pleural Mesothelioma Market with 5.7% CAGR During the Study Period (2019-2032) Expected by Analysts at DelveInsight
/PRNewswire/ -- DelveInsights Malignant Pleural Mesothelioma Market Insights report includes a comprehensive understanding of current treatment practices,...
United States United Kingdom Shruti Thakur Astrazeneca Imfinzi Pharmamar Lurbinectedin States Intratumoural
Source: prnewswire.com
Patent law in Australia: 2022 in review
This year held some fascinating developments in IP litigation, from whether AI can be named as an inventor on a patent, to a decision on PTEs with far-reaching implications. Naomi Pearce, Kate Legge and Emily Dwyer of Pearce IP report.
Source: worldipreview.com
COVID treatment molnupiravir to hit Chinese market on Friday: Sinopharm
The COVID-19 treatment molnupiravir is expected to hit the Chinese market on Friday, after passing its first import test on Wednesday, said Liu Yong, president of Sinopharm.
Liu Yong Cai Maisong National Medical Products Administration Tianjin Medical Purchase Center On Battle Against Novel Merck Sharp
Source: ecns.cn
China accelerates localized production of imported COVID treatments
The US pharmaceutical giant Merck Sharp & Dohme (MSD)s China branch announced on Wednesday that, to meet the needs of Chinese patients and help Chinas fight against COVID-19, MSD launched licensing negotiations with Sinopharm to manufacture and supply molnupiravir in China.
Liu Yong Albert Bourla Zhuang Shilihe China International Import Expo Simcere Pharmaceutical Group Drug Administration
Source: globaltimes.cn
EU Anti-Counterfeit Regulation Does Not per se Allow Repackaging of Parallel Imported or Parallel Traded Pharmaceuticals | Jones Day
In Short - The Situation: European Union ("EU") trademark law permits the repackaging of pharmaceuticals that are imported or traded in parallel from one Member State to...
Source: jdsupra.com